Prolonged Fever and Multisystem Hyperinflammation in an Adolescent Following SARS-CoV-2 Exposure: An Atypical Multisystem Inflammatory Syndrome-Like Presentation
DOI:
https://doi.org/10.52340/GBMN.2026.01.01.175Keywords:
Adolescence, D-dimer, Hyperinflammation, IL-6, Multisystem inflammatory syndrome in children, Pediatrics, Pericardial effusion, Post-COVID immune dysregulation, Prolonged fever, SynovitisAbstract
Prolonged fever with multisystem inflammation in adolescents poses a significant diagnostic challenge, especially during the viral season. Multisystem inflammatory syndrome in children (MIS-C) is a post-infectious inflammatory condition that may mimic bacterial sepsis, systemic rheumatologic disease, oncohematologic processes, or postviral dysregulation. We present a case of a 13-year-old, previously healthy boy with hectic fever, severe myalgia, and pharyngitis accompanied by elevated inflammatory markers. The clinical course was characterized by persistent fever unresponsive to broad-spectrum antibiotics, Synovitis of the knees and hips, respiratory distress with radiographic evidence of pneumonia, pericardial effusion, and mitral valve dysfunction; laboratory values include elevated cardiac troponin levels and elevated inflammatory markers (IL-6, D-dimer, and ferritin), as well as transient liver dysfunction. SARS-CoV-2 IgG was positive. Extensive infectious, hematologic, and rheumatologic evaluation was unrevealing. The patient demonstrated rapid clinical and laboratory improvement following treatment with intravenous methylprednisolone and immunoglobulin. Although the clinical picture was most compatible with MIS-C or a MIS-C-like post-SARS-CoV-2 hyperinflammatory syndrome, atypical features, including predominant respiratory involvement, gradual progression, and absence of shock, suggested a broader disease spectrum. This case highlights the diagnostic challenges of post–COVID-19 hyperinflammatory syndromes, which may present with overlapping features of infection and immune-mediated diseases.References
Brogan PA, Burns JC, Cornish J, et al. The differential diagnosis of prolonged fever and systemic inflammation in children. Arch Dis Child. 2021;106(2):114-120. doi:10.1136/archdischild-2019-318909.
World Health Organization. Multisystem Inflammatory Syndrome in Children and Adolescents Temporally Related to COVID-19. WHO Scientific Brief. Published 2020.
Centers for Disease Control and Prevention. Information for Healthcare Providers About Multisystem Inflammatory Syndrome in Children (MIS-C). Published 2020.
Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334-346. doi:10.1056/NEJMoa2021680.
Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259-269. doi:10.1001/jama.2020.10369
Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during the COVID-19 pandemic. Lancet. 2020;395(10237):1607-1608. doi:10.1016/S0140-6736(20)31094-1.
Ahmed M, Advani S, Moreira A, et al. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine. 2020;26:100527. doi:10.1016/j.eclinm.2020.100527
Henderson LA, Canna SW, Friedman KG, et al. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS–CoV-2. Arthritis Rheumatol. 2020;72(11):1791-1805. doi:10.1002/art.41454.
Consiglio CR, Cotugno N, Sardh F, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183(4):968-981.e7. doi:10.1016/j.cell.2020.09.016.
Henderson LA, Yeung RSM. MIS-C: Early lessons from immune profiling. Nat Rev Rheumatol. 2021;17:75-76. doi:10.1038/s41584-020-00566-0.
Zacharias H, Dubey S, Koduri G, D'Cruz D. Rheumatological complications of COVID-19. Autoimmun Rev. 2021;20(9):102883. doi:10.1016/j.autrev.2021.102883.
Tang KT, Hsu BC, Chen DY. Autoimmune and rheumatic manifestations associated with COVID-19: An updated systematic review. Front Immunol. 2021;12:645013. doi:10.3389/fimmu.2021.645013.
Burbelo PD, Castagnoli R, Shimizu C, et al. Autoantibodies against proteins associated with autoimmunity in COVID-19 and MIS-C. Front Immunol. 2022;13:841126. doi:10.3389/fimmu.2022.841126.
Carter MJ, Fish M, Jennings A, et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nat Med. 2020;26:1701-1707. doi:10.1038/s41591-020-1054-6.
Rowley AH. Understanding SARS-CoV-2–related multisystem inflammatory syndrome in children. Nat Rev Immunol. 2020;20:453-454. doi:10.1038/s41577-020-0367-5.
Belhadjer Z, Méot M, Bajolle F, et al. Acute heart failure in multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection. Circulation. 2020;142:429-436. doi:10.1161/CIRCULATIONAHA.120.048360.
Diorio C, McNerney KO, Lambert M, et al. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 2020;4(23):6051-6063. doi:10.1182/bloodadvances. 2020003471.